Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages

Blood. 2004 Jan 1;103(1):317-24. doi: 10.1182/blood-2003-04-1304. Epub 2003 Sep 22.

Abstract

Monocytes and macrophages participate in a wide variety of host defense mechanisms. Annexin II, a fibrinolytic receptor, binds plasminogen and tissue plasminogen activator (t-PA) independently at the cell surface, thereby enhancing the catalytic efficiency of plasmin production. We demonstrated previously that annexin II on the surface of both cultured monocytoid cells and monocyte-derived macrophages promotes their ability to remodel extracellular matrix. Here, we demonstrate that human peripheral blood monocytes represent the major circulating annexin II-expressing cell. Annexin II supported t-PA-dependent generation of cell surface plasmin and the matrix-penetrating activity of human monocytes. Compared to polymorphonuclear leukocytes, monocytes supported a 12.9-fold greater rate of plasmin generation in the presence of exogenous t-PA, and this activity was largely attributable to annexin II. Likewise, anti-annexin II IgG directed against the t-PA-binding tail domain inhibited plasminogen-dependent, cytokine-directed monocyte migration through extracellular matrix. On differentiation of monocytes to macrophages, there was a 2.4-fold increase in annexin II-specific mRNA, and a 7.9-fold increase in surface annexin II. Thioglycolate-elicited peritoneal macrophages, furthermore, displayed an additional 3.8-fold increase in annexin II surface expression compared with resident cells. Thus, annexin II-mediated assembly of plasminogen and t-PA on monocyte/macrophages contributes to plasmin generation, matrix remodeling, and directed migration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Annexin A2 / antagonists & inhibitors
  • Annexin A2 / physiology*
  • Cell Differentiation
  • Cell Movement / physiology
  • Extracellular Matrix / physiology
  • Humans
  • Immunoglobulin G / pharmacology
  • In Vitro Techniques
  • Macrophages / drug effects
  • Macrophages / physiology*
  • Monocytes / cytology
  • Monocytes / physiology*
  • Plasminogen / physiology*
  • Thioglycolates / pharmacology
  • Tissue Plasminogen Activator / physiology

Substances

  • Annexin A2
  • Immunoglobulin G
  • Thioglycolates
  • Plasminogen
  • Tissue Plasminogen Activator